| Fatty liver index | p-value | ||
---|---|---|---|---|
 < 30 | 30–59 |  ≥ 60 | ||
 | (n = 813,691) 40.5% | (n = 678,049) 33.8% | (n = 516,035) 25.7% |  |
Age, years | 59.2 ± 12.9 | 58.8 ± 11.7 | 54.2 ± 12.1 |  < 0.001 |
  < 40 | 55,977 (6.9) | 35,861 (5.3) | 59,187 (11.5) |  < 0.001 |
 40–64 | 458,800 (56.4) | 416,227 (61.4) | 347,340 (67.3) |  |
  ≥ 65 | 298,914 (36.7) | 225,961 (33.3) | 109,508 (21.2) | |
Sex |  < 0.001 | |||
 Male | 373,049 (45.9) | 400,478 (59.1) | 372,398 (72.2) |  |
 Female | 440,642 (54.2) | 277,571 (40.9) | 143,637 (27.8) | |
Smoking |  < .0001 | |||
 Non | 553,647 (68.0) | 391,127 (57.7) | 236,309 (45.8) |  |
 Former | 115,671 (14.2) | 128,594 (19.0) | 108,157 (21.0) | |
 Current | 144,373 (17.7) | 158,328 (23.4) | 171,569 (33.3) | |
Alcohol drinking |  < 0.001 | |||
 Non | 581,309 (71.4) | 419,766 (61.9) | 245,960 (47.7) |  |
 Mild to moderate | 232,382 (28.6) | 258,283 (38.1) | 270,075 (52.3) | |
Regular physical activity | 179,016 (22.0) | 139,140 (20.5) | 91,562 (17.7) |  < 0.001 |
Low income levela | 177,620 (21.8) | 141,907 (20.9) | 107,943 (20.9) |  < 0.001 |
Comorbidity | ||||
 Hypertension | 398,785 (49.0) | 404,652(59.7) | 328,008 (63.6) |  < 0.001 |
 Dyslipidemia | 296,241 (36.4) | 298,919(44.1) | 252,320 (48.9) |  < 0.001 |
CCI score | 2.4 ± 2.1 | 2.3 ± 2.1 | 2.0 ± 2.0 |  < 0.001 |
DM complication | ||||
 Retinopathy | 96,632 (11.9) | 61,667 (9.1) | 30,486 (5.9) | < 0.001 |
 ESRD | 3,010 (0.4) | 1,375 (0.2) | 639 (0.1) | < 0.001 |
 Stroke | 4,946 (0.6) | 4048 (0.6) | 2,260 (0.4) | < 0.001 |
 Ischemic heart disease | 98,760 (12.1) | 88,888 (13.1) | 57,305 (11.1) | < 0.001 |
DM duration | < 0.001 | |||
 New-onset | 278,555 (34.3) | 240,331 (35.4) | 231,933 (45.0) |  |
  < 5 years | 236,684 (29.1) | 223,672 (33.0) | 170,182 (33.0) | |
  ≥ 5 years | 298,052 (36.6) | 214,046 (31.6) | 113,920 (22.1) | |
Number of OHA use | < 0.001 | |||
 0 | 309,275 (38.0) | 259,072 (38.2) | 242,942 (47.1) |  |
 1 | 375,712 (46.2) | 319,144 (47.1) | 209,595(40.6) | |
  ≥ 2 | 128,704 (15.8) | 99,833 (14.7) | 63,498 (12.3) | |
Use of insulin | 81,394 (10.0) | 54,840 (8.1) | 32,534 (6.3) | < 0.001 |
Body mass index, kg/m2 | 22.7 ± 2.3 | 25.5 ± 2.3 | 28.2 ± 3.3 |  < 0.001 |
Waist circumference, cm | 78.9 ± 6.4 | 86.6 ± 5.7 | 93.3 ± 7.4 |  < 0.001 |
Systolic BP, mmHg | 126.0 ± 15.8 | 129.8 ± 15.5 | 132.3 ± 15.6 |  < 0.001 |
Diastolic BP, mmHg | 76.5 ± 9.9 | 79.3 ± 9.9 | 82.0 ± 10.3 |  < 0.001 |
Fasting glucose, mg/dL | 140.3 ± 46.5 | 144.4 ± 46.0 | 151.7 ± 48.1 |  < 0.001 |
Total cholesterol, mg/dL | 188.4 ± 39.8 | 198.7 ± 41.6 | 209.3 ± 45.0 |  < 0.001 |
HDL-C, mg/dL | 54.4 ± 21.6 | 50.5 ± 22.1 | 49.4 ± 27.6 |  < 0.001 |
TG, mg/dLb | 101.0 (100.9–101.1) | 156.4 (156.3–156.6) | 230.4 (230.0–230.7) |  < 0.001 |
eGFR, mL/min/1.73m2 | 84.7 ± 35.4 | 83.5 ± 34.6 | 85.3 ± 37.9 |  < 0.001 |
AST, IU/L b | 21.9 (21.9–21.9) | 25.0 (25.0–25.0) | 31.7 (31.6–31.7) |  < 0.001 |
ALT, IU/Lb | 19.5 (19.5–19.5) | 26.1 (26.1–26.1) | 37.1 (37.1–37.2) |  < 0.001 |
GGT, IU/Lb | 21.0 (20.9–21.0) | 35.4 (35.4–35.55) | 65.9 (65.8–66.0) |  < 0.001 |